Novo Nordisk A/S vs UnitedHealth Group Incorporated — Stock Comparison
Novo Nordisk A/S (NVO) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Novo Nordisk A/S scores ahead of UnitedHealth Group Incorporated on Q·Score (6.9 vs 6.1 out of 10), led by Growth (8.5 vs 5.1) and Quality (8.2 vs 5.9). UnitedHealth Group Incorporated scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for NVO (+7.8%) than for UNH (-0.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Earnings growing 67% year-over-year on 24% revenue growth.
⚠ negative free cash flow.
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
NVO vs UNH: which stock scores better overall?
Based on Q·Score, Novo Nordisk A/S (NVO) scores 6.9/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: NVO or UNH?
Novo Nordisk A/S (NVO) scores higher on Growth (8.5/10 vs 5.1/10). Novo Nordisk A/S reports revenue growth (24.0% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is NVO or UNH more attractively valued?
Novo Nordisk A/S (NVO) scores higher on Valuation (7.2/10 vs 6.5/10). NVO trades at 13.2× P/E versus UNH at 19.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about NVO vs UNH?
There are 12 analysts covering NVO with a consensus price target of $47.29, and 26 analysts covering UNH with a consensus target of $407.38. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: NVO or UNH?
Novo Nordisk A/S (NVO) scores higher on Quality (8.2/10 vs 5.9/10). Net profit margin: NVO at 37.2%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: NVO or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Financial Health (5.3/10 vs 4.8/10). Market beta: NVO at 0.35, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of NVO and UNH?
Novo Nordisk A/S (NVO) has a market capitalisation of $194.3B, while UnitedHealth Group Incorporated (UNH) has a market cap of $371.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do NVO or UNH pay dividends?
NVO pays a dividend yield of 4.11%, while UNH pays a dividend yield of 2.27%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →